GE HealthCare launches new MRI scanner
May 12, 2025
GE HealthCare (Nasdaq: GEHC)+
today unveiled Signa Sprint, an ultra-premium wide-bore 1.5% high-performance gradient MRI system.
GE HealthCare (Nasdaq: GEHC)+
today unveiled Signa Sprint, an ultra-premium wide-bore 1.5% high-performance gradient MRI system.
Launch of Zoom DuoPort enables Continuous Dual Aspiration Technique (CDAT) for safer, faster procedures
MADISON, Wis., May 6, 2025 /PRNewswire/ — The Food and Drug Administration Agency (FDA) has updated the regulatory status of Marie®, Leo Cancer Care’s upright particle therapy solution, to pending. Marie combines Leo Cancer Care’s upright patient positioning system with their upright fan beam CT scanner and can be utilized with any fixed particle beam.
The circuits could help researchers develop new treatments for fragile X syndrome and other diseases caused by mutations of a single gene.
Innovative mesh aims to improve patient outcomes by naturally absorbing into the body post-surgery.
Novocure (Baar, Switzerland) announced today that it has won a CE mark for its Optune Lua wearable device for treating metastatic non-small cell lung cancer.
ICU Medical (Nasdaq: ICUI) announced today that it received FDA 510(k) clearance for several new additions to its infusion pump portfolio.
Resmed (NYSE: RMD)+
announced today that it launched its NightOwl home sleep apnea test across the U.S.
U-Pump announced on social media that it reached a new milestone in its development of an AI-powered, reusable insulin patch pump.
SCOTTSDALE, Ariz., March 20, 2025 /PRNewswire/ — Anuncia Medical, Inc. (“Anuncia”), a pioneering company in CSF management and neurocritical care, has received Breakthrough Device Designation from the FDA for its ReFlow® EVD, an innovative solution for external ventricular drains (EVDs) used to manage brain swelling and elevated intracranial pressure.